Precigen, Inc. (PGEN)

NASDAQ: PGEN · USD

$6.09

-0.07 (-1.1%)· Recorded snapshot

Market cap	2.2B
Revenue (ttm)	85.7M
Net income (ttm)	-336.7M
EPS (ttm)	-$0.98
Shares out	358M
P/E (forward)	10.9x
Volume	3,092,184
Beta	0.92

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 85.7M
Net income (ttm): -336.7M
EPS (ttm): -$0.98
P/E (forward): 10.9x
Market cap: 2.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.9

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-837.1

P25 n/aP50 n/aP75 n/a

ROIC-35

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PGEN indicators

Market & fundamental data

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001356090
Company name	Precigen, Inc.
Country	United States
Country code	US
CUSIP number	74017N105
Earnings date	2026-11-12
Earnings time	amc
Employees	160
Employees change	17
Employees growth	11.89%
Enterprise value	$2.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US74017N1054
Last 10-K release date	2026-03-25
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.2B
Market cap category	Mid-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$6.09
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PGEN
U.S. state	Maryland
Website	https://precigen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-16.16%
EV/Sales	26.6x
FCF / EV yield	-5.05%
FCF yield	-5.19%
Forward EV/Sales	7.13x
Forward P/E	10.89x
Forward P/S	6.94x
P/B ratio	50.53x
P/S ratio	25.9x
Price / tangible book value	86.04x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-46.08%
EBITDA margin	-41.25%
Gross margin	53.01%
Operating margin	-46.08%
Pretax margin	-183.98%
Profit margin	-183.98%
Profit per employee	$-2.1M
Profitable quarters	1
Revenue per employee	$535,731
ROA	-18.14%
ROA (5Y)	-29.54%
ROCE	-28.02%
ROE	-837.08%
ROE (5Y)	-196.38%
ROIC	-34.97%
SBC / revenue	15.94%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth	1,875.05%
Revenue growth (Q)	6,322.66%
Revenue growth (QoQ)	136.44%
Revenue growth 10Y	-7.69%
Revenue growth 3Y	57.11%
Revenue growth 5Y	11.31%
Revenue growth quarters	6
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.1M
Depreciation and amortization	$4.1M
EBIT	$-39.5M
EBITDA	$-35.4M
EPS	$-0.98
FCF per share	$-0.32
Financing cash flow	$92.6M
Free cash flow	$-115.2M
Free cash flow minus SBC	$-128.9M
Gross profit	$45.4M
Investing cash flow	$24.1M
Net borrowing	$92.8M
Net cash flow	$2.6M
Net income	$-336.7M
Operating cash flow minus SBC	$-127.8M
Operating income	$-39.5M
Revenue	$85.7M
Stock-based compensation	$13.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-12.66
Book value per share	$0.12
Debt / equity	2.26
Goodwill	$15.2M
Interest coverage	-4.06
Long-term assets	$35.9M
Long-term liabilities	$97.4M
Net cash (debt)	$-60.1M
Net cash / market cap	-2.71%
Net debt / equity	1.38
Piotroski F-Score	4
Property, plant and equipment	$16.9M
Shareholders' equity	$43.6M
Tangible book value	$25.8M
Tangible book value per share	$0.07
Total assets	$170.3M
Total cash	$38.2M
Total debt	$98.3M
Total liabilities	$126.7M
WACC	9.24%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.63
Current assets	$134.4M
Current liabilities	$29.4M
Current ratio	4.58
Net working capital	$67.9M
Quick ratio	3.76
Working capital	$105M
Working capital turnover	1.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-18.38%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.16
Shareholder yield	-18.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-76.81%
10Y return CAGR	-13.6%
10Y total return	-76.81%
150-day SMA	$5.63
1D price change	-1.06%
1M price change	-21.87%
1M total return	-21.87%
1W price change	-11.35%
1W total return	-11.35%
1Y price change	40.81%
1Y return CAGR	40.85%
1Y total return	40.81%
20-day SMA	$7.10
200-day SMA	$5.24
3M price change	11.72%
3M total return	11.72%
3Y price change	499.51%
3Y return CAGR	81.64%
3Y total return	499.51%
50-day SMA	$7.24
50-day SMA vs 200-day SMA	50over200
52-week high	$8.98
52-week high date	2026-09-30
52-week low	$3.04
52-week low date	2026-03-25
5Y price change	34.56%
5Y return CAGR	6.12%
5Y total return	34.56%
6M price change	52.9%
6M total return	52.9%
All-time high	$69.45
All-time high date	2015-08-06
All-time low	$0.65
All-time low date	2024-12-16
Average true range (ATR)	$0.39
Average volume	4.6M
Beta (1Y)	0.85
Beta (2Y)	1.61
Beta (5Y)	0.92
Change from 52-week high	-32.24%
Change from 52-week low	100.16%
Change from all-time high	-91.28%
Change from all-time low	829.68%
Change from open	0.58%
Day's gap	-1.63%
Dollar volume	$18.8M
High price	$6.35
Low price	$6.04
Monthly RSI	60.43
Open price	$6.05
Position in 52-week range	14.52%
Premarket change	0.98%
Premarket close	$6.15
Premarket price	$6.21
Premarket volume	2.1K
Previous close	$6.15
Price vs 150-day SMA	7.55%
Price vs 20-day SMA	-14.71%
Price vs 200-day SMA	15.47%
Price vs 50-day SMA	-16.33%
Relative volume	0.68
RSI	34.28
Sharpe ratio	0.76
Sharpe ratio (3Y)	1.03
Sharpe ratio (5Y)	0.44
Sortino ratio	1.36
Sortino ratio (3Y)	1.89
Sortino ratio (5Y)	0.79
Volume	3.1M
Weekly RSI	49.97
YTD price change	44.86%
YTD total return	44.86%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	194.6M
Float percentage	54.35%
Shares change (QoQ)	16.76%
Shares change (YoY)	18.38%
Shares held by insiders	11.71%
Shares held by institutions	39.33%
Shares outstanding	358M
Short % of float	24.43%
Short % of shares	13.28%
Short ratio	10.2 days

Deeper analysis on PGEN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PGEN report

Is a complete PGEN research report available?

No complete published report is available for Precigen, Inc. (PGEN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Precigen, Inc. (PGEN)

Price

Financial snapshot

Fair-value bridge

Latest news · PGEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PGEN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PGEN

Frequently asked questions